【Good News】Haibu Pharmaceutical's Lacosamide Oral Solution (Brand Name: Vianzu®) has been successfully approved!
Classification:
Company News
Release time:
2023-09-18
Beijing Haibu Pharmaceutical Technology Co., Ltd. (referred to as "Haibu Pharmaceutical") was established in 2005 and is a high-tech enterprise with "chemical drug research and development" as its core capability. It has a research and development center in Beijing, a pilot verification center for raw materials and formulations, and a GMP industrial production base. The company mainly engages in CRO services for raw materials and formulations, joint licensing with MAH, related applications for raw materials, and commercial supply of pharmaceutical intermediates. The R&D products cover multiple therapeutic areas including anti-tumor, anti-depression, anti-epilepsy, anti-anxiety, cardiovascular, digestive system, respiratory system, etc.
Haibu Pharmaceutical has been awarded the title of "Top 20 Pharmaceutical R&D Companies in China" for several consecutive years and has been recognized as a "Specialized, Refined, Characteristic and Innovative" enterprise in Beijing, a "National High-tech Enterprise", a "Beijing Science and Technology Research Development Institution", and a "Beijing Yizhuang Enterprise Innovation Center", among others.
Beijing Hope Pharmaceutical Co., Ltd.
